|
Volumn 18, Issue 1, 2010, Pages 64-65
|
Bilateral toxoplasma retinochoroiditis in a patient with chronic myeloid leukemia treated with imatinib mesylate
|
Author keywords
Chronic myeloid leukemia; Imatinib; Retinochoroiditis; Toxoplasma gondii
|
Indexed keywords
ABELSON KINASE;
BCR ABL PROTEIN;
COTRIMOXAZOLE;
IMATINIB;
IMMUNOGLOBULIN G;
PREDNISOLONE;
ADULT;
ARTICLE;
BLOOD CELL COUNT;
CANCER PATIENT;
CASE REPORT;
CHORIORETINITIS;
CHRONIC MYELOID LEUKEMIA;
DRUG DOSE REDUCTION;
FOLLOW UP;
GENERAL CONDITION IMPROVEMENT;
HUMAN;
HUMAN TISSUE;
MALE;
NONHUMAN;
OPHTHALMOSCOPY;
POLYMERASE CHAIN REACTION;
THERAPY EFFECT;
TOXOPLASMA GONDII;
TOXOPLASMA RETINOCHOROIDITIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
VISUAL ACUITY;
VITREOUS BIOPSY;
ANTINEOPLASTIC AGENTS;
CHORIORETINITIS;
DNA;
GENOME;
HUMANS;
IMMUNE TOLERANCE;
IMMUNOGLOBULIN G;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MALE;
MIDDLE AGED;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
TOXOPLASMA;
TOXOPLASMOSIS, OCULAR;
TREATMENT OUTCOME;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
VISUAL ACUITY;
|
EID: 76749132575
PISSN: 09273948
EISSN: 17445078
Source Type: Journal
DOI: 10.3109/09273940903315792 Document Type: Article |
Times cited : (5)
|
References (5)
|